Gene · 2271
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| S-lactoyl modification of KEAP1 by a reactive glycolytic metabolite activates NRF2 signaling. | Proc Natl Acad Sci U S A | 2023 | 37155889 | PubTator, text mining | PubMed |
| The expression pattern of pyruvate dehydrogenase kinases predicts prognosis and correlates with immune exhaustion in clear cell renal cell carcinoma. | Sci Rep | 2023 | 37147361 | PubTator, text mining | PubMed |
| Genomic and transcriptomic features between primary and paired metastatic fumarate hydratase-deficient renal cell carcinoma. | Genome Med | 2023 | 37131267 | PubTator, text mining | PubMed |
| Metabolism-based targeting of MYC via MPC-SOD2 axis-mediated oxidation promotes cellular differentiation in group 3 medulloblastoma. | Nat Commun | 2023 | 37130865 | PubTator, text mining | PubMed |
| Species Delineation and Comparative Genomics within the Campylobacter ureolyticus Complex. | J Clin Microbiol | 2023 | 37129508 | PubTator, text mining | PubMed |
| Therapeutic eradication choices in Helicobacter pylori infection in children. | Ther Adv Gastroenterol | 2023 | 37124372 | PubTator, text mining | PubMed |
| An evolving view of complex II-noncanonical complexes, megacomplexes, respiration, signaling, and beyond. | J Biol Chem | 2023 | 37119852 | PubTator, text mining | PubMed |
| Prevalence and clinical significance of co-existing mutations in MED12 and FH in uterine fibroids of Australian women. | Front Reprod Health | 2023 | 37113812 | PubTator, text mining | PubMed |
Understanding the Pathogenesis of Cardiac Complications in Patients with Propionic Acidemia and Exploring Therapeutic Alternatives for Those Who Are Not Eligible or Are Waiting for Liver Transplantation. | Metabolites | 2023 | 37110221 | PubTator, text mining | PubMed |
| Regulation of Cell Proliferation and Nrf2-Mediated Antioxidant Defense: Conservation of Keap1 Cysteines and Nrf2 Binding Site in the Context of the Evolution of KLHL Family. | Life (Basel) | 2023 | 37109574 | PubTator, text mining | PubMed |
| Mitochondrial Dysfunction: A Cellular and Molecular Hub in Pathology of Metabolic Diseases and Infection. | J Clin Med | 2023 | 37109219 | PubTator, text mining | PubMed |
| Detection of Novel Biomarkers in Pediatric Autoimmune Hepatitis by Proteomic Profiling. | Int J Mol Sci | 2023 | 37108648 | PubTator, text mining | PubMed |
| Regulative Roles of Metabolic Plasticity Caused by Mitochondrial Oxidative Phosphorylation and Glycolysis on the Initiation and Progression of Tumorigenesis. | Int J Mol Sci | 2023 | 37108242 | PubTator, text mining | PubMed |
| Redox-Based Strategies against Infections by Eukaryotic Pathogens. | Genes (Basel) | 2023 | 37107536 | PubTator, text mining | PubMed |
| Oxidative Stress and Antioxidants in Uterine Fibroids: Pathophysiology and Clinical Implications. | Antioxidants (Basel) | 2023 | 37107181 | PubTator, text mining | PubMed |
| Fumarate hydratase-deficient renal cell carcinoma: a case report and review of the literature. | J Med Case Rep | 2023 | 37076922 | PubTator, text mining | PubMed |
| Durable Response to Pazopanib in a Patient with Fumarate Hydratase-Mutant Tubulocystic Renal Cell Carcinoma. | Case Rep Oncol | 2023 | 37069897 | PubTator, text mining | PubMed |
| Multi-omics analyses reveal ClpP activators disrupt essential mitochondrial pathways in triple-negative breast cancer. | Front Pharmacol | 2023 | 37063293 | PubTator, text mining | PubMed |
| Circulating succinate-modifying metabolites accurately classify and reflect the status of fumarate hydratase-deficient renal cell carcinoma. | J Clin Invest | 2023 | 37053010 | PubTator, text mining | PubMed |
| NAGS, CPS1, and SLC25A13 (Citrin) at the Crossroads of Arginine and Pyrimidines Metabolism in Tumor Cells. | Int J Mol Sci | 2023 | 37047726 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2271/papers?page=21